Overview

Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies

Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the effect of leucovorin in preventing or reducing Folotyn-related Grade 2 or higher oral mucositis.
Phase:
Phase 2
Details
Lead Sponsor:
Acrotech Biopharma LLC
Spectrum Pharmaceuticals, Inc
Collaborator:
Axis Clinicals Limited
Treatments:
Aminopterin
Folic Acid
Hydroxocobalamin
Leucovorin
Vitamin B 12
Vitamin B Complex
Vitamins